Articles tagged with: Smoldering Multiple Myeloma
The sun is shining, and our cats are dreaming in sunbeams about catching quick-footed squirrels just out of reach. Summer … It feels good to finally be here, and so it’s fitting that I now conclude the three-part series on our journey from the dark days of my husband Daniel’s initial diagnosis to the brighter days of the present.
As I mentioned in my last column, we moved to Houston in 2012 so that Daniel could be treated by a myeloma specialist at the MD Anderson Cancer Center. I truly …
This year’s American Society of Clinical Oncology (ASCO) annual meeting in Chicago ended last Tuesday.
The day before the meeting ended was the busiest day at the meeting with regard to myeloma research. It featured a session of oral presentations in the morning and a poster session in the afternoon. In addition, an education session was held in the afternoon that included one myeloma-related talk, given by Dr. Leif Bergsagel of the Mayo Clinic, about progress in the treatment of multiple myeloma (article in the ASCO 2014 Educational Book). …
After my husband Daniel’s initial diagnosis with monoclonal gammopathy of undetermined significance (MGUS) in 2012, I couldn’t shake the feeling that the “treatment” plan of watching and waiting, which had been suggested by a local hematologist/oncologist, was not enough.
The hematologist/oncologist wasn’t a myeloma specialist, and he wasn’t connected to a research hospital. My mother had ovarian center in the 1990s, and I know what an impact it had on her recovery to have had a research hospital involved in her treatment.
I believed that we couldn’t get the …
The American Society of Clinical Oncology will hold its 50th annual meeting May 30 through June 3 in Chicago.
Similar to previous years, more than 25,000 physicians and researchers from all over the world are expected to attend the five-day meeting to discuss the current research in cancer treatment and care.
During the meeting, there will be presentations about all areas of cancer, including many focused specifically on multiple myeloma. The ASCO website currently lists information about more than 60 myeloma-related studies (included under either the “multiple myeloma” or “
Results from a German retrospective study show that repeated whole-body magnetic resonance imaging may identify smoldering myeloma patients with an increased risk of progressing to symptomatic multiple myeloma.
In their study, the German researchers looked at smoldering myeloma patients who had whole-body magnetic resonance imaging (MRI) scans at the time of diagnosis and during regular follow-up visits.
The researchers found that patients whose follow-up scans showed progression of their disease had a 16.5-fold higher risk of progressing to symptomatic myeloma than patients who had stable disease based on their follow-up …